Status:
UNKNOWN
Personal Precise Treatment on Psoriasis and Psoriatic Arthritis
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Dermatologic Disease
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Part of psoriasis and psoriatic arthritis patients treated with biologics and met primary failure. Therefore, we are going to create a cell based platform to evaluate the treatment effects of differen...
Detailed Description
PBMCs isolated from psoriasis and psoriatic arthritis and incubated with Group A streptococcus and different biologics for 24 hours. Cytokines expression in the culture supernatants will be measured a...
Eligibility Criteria
Inclusion
- 1\. Healthy control without underline disease such as psoriasis and psoriatic arthritis. 2. Psoriasis been diagnosed for over six months and PASI \>10. 3.Psoriatic arthritis been diagnosed for over six months and \>1 swallow and tender joints
Exclusion
- nil
Key Trial Info
Start Date :
May 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04915105
Start Date
May 31 2021
End Date
May 31 2025
Last Update
June 7 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.